Biotech

All Articles

BioAge eyes $180M from IPO, private positioning for weight problems tests

.BioAge Labs is actually considering all around $180 thousand in preliminary earnings from an IPO as...

Merck's LAG-3 combination falls short colon cancer cells phase 3 study

.An effort by Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colorectal cancer ...

Spanish VC shuts $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has actually closed a fund of 180 thousand europeans ($ 200 thousand), ...

BioAge generates $198M coming from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is bringing in just about $200 thousand via its own Nasdaq IPO this morning, with the p...

Acadia delivers BMS veterinarian aboard as chief executive officer-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...

Cassava spends $40M over apparently deceiving Alzheimer's improve

.Cassava Sciences has accepted to spend $40 thousand to fix an examination right into cases it made ...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has actually picked up options on pair of Evaxion Biotech injection candidates, spen...

Enanta's RSV antiviral crushes popular tons in challenge research study

.Enanta Pharmaceuticals has actually linked its own respiratory system syncytial infection (RSV) ant...

Biogen cans SAGE-324 partnership after essential tremor fail

.Biogen has administered the final rites to its cooperation with Sage Therapeutics on SAGE-324, ditc...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout credit ratings

.On the very same time that some Parkinson's condition drugs are actually being actually cast doubt ...